Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: an alternative therapy for patients with major depressive disorder

Clinical & Developmental Immunology
María Eugenia HernándezLenin Pavón

Abstract

Major depressive disorder (MDD) is a psychiatric illness that presents as a deficit of serotonergic neurotransmission in the central nervous system. MDD patients also experience alterations in cortisol and cytokines levels. Treatment with selective serotonin reuptake inhibitors (SSRIs) is the first-line antidepressant regimen for MDD. The aim of this study was to determine the effect of a combination of SSRIs and an immunomodulator-human dialyzable leukocyte extract (hDLE)-on cortisol and cytokines levels. Patients received SSRIs or SSRIs plus hDLE. The proinflammatory cytokines IL-1 β , IL-2, and IFN- γ ; anti-inflammatory cytokines IL-13 and IL-10; and 24-h urine cortisol were measured at weeks (W) 0, 5, 20, 36, and 52 of treatment. The reduction in cortisol levels in the SSRI-treated group was 30% until W52, in contrast, the combined treatment induced a 54% decrease at W36. The decline in cortisol in patients who were treated with SSRI plus hDLE correlated with reduction of anti-inflammatory cytokines and increases levels of proinflammatory cytokines at the study conclusion. These results suggest that the immune-stimulating activity of hDLE, in combination with SSRIs, restored the pro- and anti-inflammatory cytokine balance ...Continue Reading

References

May 1, 1990·Biological Psychiatry·R M Sapolsky, P M Plotsky
Nov 1, 1985·The American Journal of Psychiatry·G J GormleyH Y Meltzer
Nov 1, 1984·Biological Psychiatry·G S AlexopoulosP E Stokes
May 1, 1993·Psychiatry Research·D A AxelsonK R Krishnan
Jul 22, 1998·The Psychiatric Clinics of North America·P M PlotskyC B Nemeroff
Dec 5, 1998·International Journal of Immunopharmacology·S Estrada-ParraI Estrada-Garcia
Jan 15, 1999·Endocrine Research·C DelarueH Vaudry
Mar 19, 1999·Brain, Behavior, and Immunity·R Mössner, K P Lesch
Jun 28, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M KuberaM Maes
Oct 12, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·F Holsboer
Mar 29, 2001·Biological Psychiatry·C M Pariante, A H Miller
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·G PizzaR Capanna
Jan 5, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Zubin BhagwagarPhilip J Cowen
Mar 23, 2002·Journal of Clinical Psychopharmacology·Patrizia BlardiPaolo Castrogiovanni
Dec 6, 2002·The International Journal of Neuropsychopharmacology·Ziad Kronfol
Feb 15, 2003·Cellular and Molecular Neurobiology·Lucimey Lima, Mary Urbina
May 22, 2003·Neuroscience Letters·Miho Okuyama-TamuraItaru Kojima
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Ronald C KesslerUNKNOWN National Comorbidity Survey Replication
Jul 23, 2003·British Journal of Pharmacology·Carmine M ParianteRobert W Kerwin
Jan 22, 2005·The Journal of Physiology·Graeme I LancasterMichael Gleeson
Aug 13, 2005·Scandinavian Journal of Rheumatology·W U KimH Y Kim
Feb 7, 2006·Journal of Neuroimmunology·Lenin PavónGerhard Heinze
Mar 25, 2006·Nature Reviews. Immunology·Esther M Sternberg
May 19, 2006·Psychoneuroendocrinology·Thomas J HuberOliver T Wolf
Apr 17, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yong-Ku KimJung-Bum Kim
Aug 19, 2007·Neuroimmunomodulation·Alfonso GonzálezLucimey Lima
Oct 9, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yong-Ku KimBun-Hee Lee
Mar 28, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Livia A CarvalhoCarmine M Pariante
May 23, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Daniel Anthony JohnsonSarah Elizabeth Gartside
Aug 19, 2008·Journal of Psychiatric Research·Cornelius SchüleRainer Rupprecht
Sep 23, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·María Eugenia HernándezLenin Pavón
Apr 22, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Patricia A ZunszainCarmine M Pariante
Jul 29, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jonas HannestadMichael Bloch
Nov 15, 2011·Neuroendocrinology·A T Spijker, E F C van Rossum
Jul 25, 2012·Annals of the New York Academy of Sciences·Marni N Silverman, Esther M Sternberg

❮ Previous
Next ❯

Citations

Apr 14, 2015·Journal of Medicinal Food·Giovanna Merchand-ReyesSonia Mayra Pérez-Tapia
Mar 25, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Michael NguyenAllan V Kalueff
May 12, 2015·Journal of Immunology Research·Rodrigo ArreolaLenin Pavón
Jan 17, 2015·European Journal of Pharmacology·S Mechiel KorteBerend Olivier
Mar 25, 2014·Frontiers in Integrative Neuroscience·Javier Velázquez-MoctezumaBeatriz Gómez-González
Aug 16, 2016·BioMed Research International·Emilio Medina-RiveroSonia Mayra Pérez-Tapia
Oct 20, 2018·Biomédica : revista del Instituto Nacional de Salud·Leslie Alejandra RamírezJuan Carlos Pineda
Sep 25, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gregorio Carballo-UicabEmilio Medina-Rivero
Apr 8, 2017·BioMed Research International·Carlos Pérez-AlvaradoD Guillermo Pérez Ishiwara
Apr 12, 2019·European Journal of Pharmacology·Adriana Ribeiro SilvaVinicius de Frias Carvalho

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

Prisma
GraphPad

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.